Dr. Neda Laiteerapong provides commentary on a study that looks at the frequency of testing for adults with controlled type 2 diabetes, and the potential clinical implications. Read the full commentary here as published in The BMJ.
Recent Posts
- CDRP director urges support of CDC’s National Diabetes Prevention Program and HRSA’s Health Center Program in LA Times
- Award-winning Behavioral Health Integration Program, led by CDRP associate director Neda Laiteerapong, mobilizes primary care providers to address the mental health care shortage
- CDRP Hosts 2025 Mt Hood Diabetes Challenge
- Stacy Tessler Lindau’s bionic breast project featured in Chicago Tribune
- Now streaming: Chronic Diseases and Medical Decision-Making Workshop